Your browser doesn't support javascript.
loading
Characterization and Potential Mitigation of Corneal Effects in Nonclinical Toxicology Studies in Animals Administered Depatuxizumab Mafodotin.
Loberg, Lise I; Henriques, Tracy A; Johnson, Julie K; Miller, Paul E; Ralston, Sherry L.
Affiliation
  • Loberg LI; Preclinical Safety, AbbVie, Inc., North Chicago, Illinois, USA.
  • Henriques TA; Preclinical Safety, AbbVie, Inc., North Chicago, Illinois, USA.
  • Johnson JK; Preclinical Safety, AbbVie, Inc., North Chicago, Illinois, USA.
  • Miller PE; Ocular Services on Demand (OSOD), Madison, Wisconsin, USA.
  • Ralston SL; Preclinical Safety, AbbVie, Inc., North Chicago, Illinois, USA.
J Ocul Pharmacol Ther ; 38(7): 471-480, 2022 09.
Article in En | MEDLINE | ID: mdl-35537481
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Toxic Optic Neuropathy Limits: Animals Language: En Journal: J Ocul Pharmacol Ther Journal subject: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Toxic Optic Neuropathy Limits: Animals Language: En Journal: J Ocul Pharmacol Ther Journal subject: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Country of publication: